|
B4GALT6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
7.992400E-04 |
| Normal-vs-Stage3 |
3.68559627261789E-11 |
| Normal-vs-Stage4 |
2.15950000104215E-08 |
| Stage1-vs-Stage2 |
4.854200E-01 |
| Stage1-vs-Stage3 |
3.229600E-01 |
| Stage1-vs-Stage4 |
3.805800E-01 |
| Stage2-vs-Stage3 |
2.914200E-01 |
| Stage2-vs-Stage4 |
3.046400E-01 |
| Stage3-vs-Stage4 |
9.802400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.751030E-04 |
| Normal-vs-Asian |
5.79099999999944E-05 |
| Caucasian-vs-AfricanAmerican |
6.833600E-01 |
| Caucasian-vs-Asian |
8.278000E-02 |
| AfricanAmerican-vs-Asian |
7.215500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.32827124036339E-15 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
3.264500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
2.56461518688411E-14 |
| Normal-vs-Age(61-80Yrs) |
4.69502214883732E-12 |
| Normal-vs-Age(81-100Yrs) |
4.975900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.719000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.810600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.182800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.190400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.261200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.862100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.173500E-04 |
| Classical-VS-Follicular |
5.969400E-01 |
| Classical-VS-Other |
6.845200E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
2.466000E-02 |
| Tall-VS-Other |
4.591600E-01 |
| Tall-VS-Normal |
1.9932099999953E-05 |
| Follicular-VS-Other |
8.236000E-01 |
| Follicular-VS-Normal |
2.16939999297949E-09 |
| Other-VS-Normal |
5.475600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
2.64230004543009E-09 |
| N0-vs-N1 |
9.613200E-01 |
|
|
